ORKA-001

all catalysts(0)

nothing on the calendar yet

News(2)

• Oruka surges as long-acting psoriasis drug shows early promise
  A therapy that works similarly to AbbVie’s blockbuster Skyrizi appeared more potent in a mid-stage trial and has the potential to be dosed less frequently.
  biopharma_dive · 3mo ago
• STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study
  A long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical trial, its maker, Oruka Therapeutics, reported.
  stat · 3mo ago